Robert A Fowler
Robert A Fowler is an expert in Critical care at Sunnybrook Health Science Centre (Canada). As of October 2026, ScienceLeadR ranks Robert A Fowler in the top 1% of experts worldwide for Critical Illness, Coronavirus Infections and COVID-19. Robert A Fowler has authored 628 publications, the most recent in 2026, and is an investigator in 48 clinical trials, 6 of them ongoing. SLR score: 2,491 (community average: 125). How the SLR is computed.
LeadR Profile
Critical care
Subspecialties: Infectiology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 628
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 48
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 21
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Pilot Feasibility Trial of a Peer Support Program for Trauma Survivors NCT07275892 — pilots, compassion fatigue, communication, rehabilitation, amputation, surgical, recycling, self care, work, research, wounds and injuries, burns, mental health | N/A | Not yet recruiting | 2026 |
| BALANCE Vanguard Phase NCT05893147 — bacteremia, moxifloxacin, levofloxacin, blood, ciprofloxacin, trimethoprim, amoxicillin, sulfamethoxazole, ertapenem, cefixime, sepsis, meropenem, trimethoprim, sulfamethoxazole drug combination, cephalexin, beta-lactams, cephalosporins, ceftriaxone, blood culture, retention, psychology, bacteria, cefadroxil, carbapenems, infections, catheters, lactams | N/A | Recruiting | 2023 |
| Reducing Low value Care for Trauma Admissions NCT05744154 — feedback, drug-related side effects and adverse reactions, budgets, wounds and injuries | N/A | Not yet recruiting | 2023 |
| Canadian Adaptive Platform Trial of Treatments for COVID 19 in Community Settings NCT05614349 — sars-cov-2, vitamins, pharmaceutical preparations, ascorbic acid, ritonavir, drug combinations, antioxidants, covid-19, therapeutics, severe acute respiratory syndrome-related coronavirus, outpatients, lycopene | Phase 3 | Active not recruiting | 2023 |
| HNFO With or Without Helmet NIV for Oxygenation Support in Acute Respiratory Failure Pilot RCT NCT05078034 — work of breathing, noninvasive ventilation, pilots, respiration, respiratory insufficiency, patient comfort, work, ventilation | N/A | Active not recruiting | 2022 |
LeadR Networks
Main global connection map